Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises SAF-HOLLAND on its takeover bid for Haldex
Mandate

Vinge advises SAF-HOLLAND on its takeover bid for Haldex

July 18, 2016

SAF-HOLLAND S.A. (Frankfurt Stock Exchange), through a wholly-owned subsidiary, has announced an all-cash offer to the shareholders of Haldex AB (publ) (Nasdaq Stockholm). The total offer value for all outstanding shares in Haldex amounts to SEK 4,165 million.
 
Vinge advises SAF-HOLLAND. The Vinge team is headed by capital markets and public M&A partner Erik Sjöman and includes Anders Strid, Jo-Anna Nordström, Ludvig Frithiof and Astrid Karlsson, and Henrik Ossborn and Fredrik Christiansson (financing).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026